Explore more publications!
News Break! Middle East
Got News to Share?

News Break! Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Break! Middle East.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 6, 2025

How to Get Started with Reformer Pilates in Jeddah: KARVE's Approach to Making Movement a Lifestyle
December 6, 2025

How to Get Started with Reformer Pilates in Jeddah: KARVE's Approach to Making Movement a Lifestyle

Indeterminate EIN Presswire
Commercial Operation Begins at the Masader Al-Haq Solar Power Plant in Ma’an with a Capacity of 50 MW
December 6, 2025

Commercial Operation Begins at the Masader Al-Haq Solar Power Plant in Ma’an with a Capacity of 50 MW

Indeterminate EIN Presswire
Unveiling Expertise: HGMC's Industrial Brewing Equipment at CBCE, Positioning China's Top Suppliers
December 6, 2025

Unveiling Expertise: HGMC's Industrial Brewing Equipment at CBCE, Positioning China's Top Suppliers

Indeterminate EIN Presswire
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 6, 2025

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架，可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤
December 6, 2025

Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架，可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤

Indeterminate GlobeNewswire
Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review
December 6, 2025

Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review

Indeterminate GlobeNewswire
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 6, 2025

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)

Indeterminate GlobeNewswire
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
December 6, 2025

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire
DeFi Crypto Mutuum Finance Prepares for 20% Price Increase as Phase 6 Nears Completion
December 6, 2025

DeFi Crypto Mutuum Finance Prepares for 20% Price Increase as Phase 6 Nears Completion

Indeterminate GlobeNewswire
New Crypto Coin Mutuum Finance Nears 100% of Phase 6 Allocation as Price Shift Approaches
December 6, 2025

New Crypto Coin Mutuum Finance Nears 100% of Phase 6 Allocation as Price Shift Approaches

Indeterminate GlobeNewswire
Sapu Nano 公布新的药代动力学数据显示，与口服给药相比，静脉注射 Sapu003 可将依维莫司的胃肠道积累量减少 67 倍
December 6, 2025

Sapu Nano 公布新的药代动力学数据显示，与口服给药相比，静脉注射 Sapu003 可将依维莫司的胃肠道积累量减少 67 倍

Indeterminate GlobeNewswire
Sapu Nano 發表最新藥物動力學數據，顯示與口服劑量相比，靜脈注射 Sapu003 可將積聚在腸胃的依維莫司 (Everolimus) 量降低達 67 倍
December 6, 2025

Sapu Nano 發表最新藥物動力學數據，顯示與口服劑量相比，靜脈注射 Sapu003 可將積聚在腸胃的依維莫司 (Everolimus) 量降低達 67 倍

Indeterminate GlobeNewswire
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease
December 6, 2025

Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease

Indeterminate GlobeNewswire
Copper Quest Closes $1,927,000 Private Placement
December 6, 2025

Copper Quest Closes $1,927,000 Private Placement

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions